The U.S. Food and Drug Administration approved Merilog as biosimilar to Novolog for the improvement of glycemic control in adults and pediatric ...

A popular diabetes drug just got a major new approval — and it could be a game-changer for millions of Americans at risk for kidney failure.

announced today that the U.S. Food and Drug Administration (FDA) has approved Susvimo ® (ranibizumab injection) 100 mg/mL for ...

People with diabetes should eat as much protein as people who don't have diabetes. In a healthy diet, roughly 10% to 35% of your daily calories should come from protein. Protein itself does not have ...

Engulfing Bearish 15 69 Jan 29, 2025 12:15 ...

Announcing a new article publication for BIO Integration journal. Diabetes, a common metabolic condition, poses a substantial health burden worldwide. To revolutionize diabetes management, enhance ...

expanding its use beyond diabetes to tackle chronic kidney disease and cardiovascular risks. The move solidifies Ozempic as the most broadly indicated GLP-1 drug on the market. In the FLOW trial ...

LOS ANGELES - A new clinical trial in The BMJ found that combining calorie restriction with the diabetes drug dapagliflozin reversed type 2 diabetes in nearly half of participants. The approach ...

Share on Pinterest An SGLT-2 inhibitor drug plus a moderately calorie-restrictive diet may be the best approach for achieving diabetes remission. Image credit: Xvision/Getty Images. About 828 ...

On this week’s episode of her podcast, this theme returned in a conversation around prescription components of weight loss plans like the diabetes drug Ozympec, which has become a sensation for ...

NEW YORK, Jan 22 — A new study highlighted Monday the potential benefits of popular diabetes drugs on a wide range of health issues including dementia and cardiovascular diseases, although experts ...

Stimulant medications are considered the first-line treatment for ADHD for some very good reasons. Here are 6 things to know about stimulant medications in ADHD. Attention Deficit Hyperactivity ...